Pierre EV/EBIT
Cos'è EV/EBIT di Pierre?
EV/EBIT di Pierre Corp. è N/A
Qual è la definizione di EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT di aziende nel Health Care settore su NYSE rispetto a Pierre
Cosa fa Pierre?
Fourth Wave Energy, Inc. operates as a climate tech company. The company designs energy system to reduce energy consumption and associated carbon emissions in residences and commercial buildings. Its energy system is based on combining solar power and other energy technologies into one fully integrated system. The company is headquartered in San Jose, California.
Aziende con ev/ebit simili a Pierre
- Microbot Medical Inc ha EV/EBIT di N/A
- Penbar Capital Ltd ha EV/EBIT di N/A
- Future Consumer ha EV/EBIT di N/A
- Orgenesis Inc ha EV/EBIT di N/A
- Sejal Glass ha EV/EBIT di N/A
- Castlight Health Inc ha EV/EBIT di N/A
- Pierre ha EV/EBIT di N/A
- Genfit SA ha EV/EBIT di N/A
- Fangdd Network Ltd ha EV/EBIT di N/A
- Achiko AG ha EV/EBIT di N/A
- Calithera Biosciences Inc ha EV/EBIT di N/A
- UroGen Pharma Ltd ha EV/EBIT di N/A
- Magenta Therapeutics Inc ha EV/EBIT di N/A